<?xml version="1.0" encoding="UTF-8"?><Media xmlns:cdr="cips.nci.nih.gov/cdr" BlockedFromVOL="Yes">
 
 <MediaTitle>Childhood Vascular Tumors - Baselga Figure</MediaTitle>
 <PhysicalMedia>
  <ImageData>
   <ImageType>photo</ImageType>
   <ImageEncoding>JPEG</ImageEncoding>
   <Color>Color</Color>
   <Labeled>Yes</Labeled>
   <LabelName language="en">Preprogression</LabelName><LabelName language="en">Postprogression</LabelName><LabelName language="en">A</LabelName><LabelName language="en">B</LabelName><LabelName language="en">C</LabelName><LabelName language="en">D</LabelName><LabelName language="en">E</LabelName><ImageDimensions>
    <HeightPixels>1803</HeightPixels>
    <WidthPixels>946</WidthPixels>
   </ImageDimensions>
  </ImageData>
 </PhysicalMedia>
 <MediaSource>
  <OriginalSource>
   <Creator>JAMA Dermatology</Creator>
   <SourcePublication>Baselga E, Roe E, Coulie J, et al.: Risk Factors for Degree and Type of Sequelae After Involution of Untreated Hemangiomas of Infancy. JAMA Dermatology, Volume 152 (Issue 11), Pages 1239–1243, 2016.</SourcePublication><DateCreated>2017-12-20</DateCreated>
   <SourceFilename>Baselga Fig 1 for Ch Vascular Tumors JPEG file 12-20-17</SourceFilename>
  </OriginalSource>
 </MediaSource>
 <PermissionInformation>
    <PermissionRequested>Yes</PermissionRequested>
    <PermissionRequestDate>2017-11-29</PermissionRequestDate>
    <PermissionResponse>Permission Granted</PermissionResponse>
    
    
    
    <PermissionResponseDate>2017-12-15</PermissionResponseDate><PublisherPermissionText>Reproduced with permission from JAMA Dermatology. 2016. 152 (11): 1239–1243. Copyright © (2016) American Medical Association. All rights reserved.</PublisherPermissionText><ApprovedUse>
     <Summary cdr:ref="CDR0000774170">Childhood Vascular Tumors Treatment</Summary>
     
    </ApprovedUse>
    <SpanishTranslationPermissionRequested>No</SpanishTranslationPermissionRequested>
    
    <CitationLink cdr:ref="CDR0000791440">Risk Factors for Degree and Type of Sequelae After Involution of Untreated Hemangiomas of Infancy.</CitationLink></PermissionInformation><MediaContent>
  <Categories>
   <Category>abnormal cells or tissues</Category>
  </Categories>
  <Diagnoses>
   <Diagnosis cdr:ref="CDR0000665618">hemangioma</Diagnosis>
  </Diagnoses>
  
  <ContentDescriptions>
   <ContentDescription audience="Health_professionals" language="en">Photographs showing different types of hemangioma sequelae, pre-progression and post-progression. </ContentDescription><ContentDescription audience="Health_professionals" language="es">Las fotografías muestran diferentes tipos de secuelas de hemangiomas, antes y después de la progresión.</ContentDescription>
  </ContentDescriptions>
  <Captions>
   <MediaCaption audience="Health_professionals" language="en">Examples of different types of sequelae. A, deep hemangioma that regressed without sequelae; B, superficial hemangioma that left only telangiectasia; C, mixed hemangioma that left anetodermic skin; D, mixed hemangioma that left redundant skin; and E, mixed hemangioma that left fibrofatty tissue. Reproduced with permission from JAMA Dermatology. 2016. 152 (11): 1239–1243. Copyright © (2016) American Medical Association. All rights reserved.</MediaCaption>
  <MediaCaption audience="Health_professionals" language="es">Ejemplos de tipos diferentes de secuelas. A, hemangioma profundo que remitió sin secuelas; B, hemangioma superficial que solo dejó telangiectasias; C, hemangioma compuesto que dejó la piel anetodérmica; D, hemangioma compuesto que dejó piel redundante; y E, hemangioma compuesto que dejó tejido fibroadiposo. Preprogression: antes de la progresión; Postprogression: después de la progresión.</MediaCaption></Captions>
 </MediaContent>
 <ProposedUse>
  <Summary cdr:ref="CDR0000774170">Childhood Vascular Tumors Treatment</Summary><Summary cdr:ref="CDR0000779919">Tratamiento de los tumores vasculares infantiles</Summary>
  
 </ProposedUse>
 <ProcessingStatuses><ProcessingStatus>
        <ProcessingStatusValue>Ready for Publishing</ProcessingStatusValue>
        <ProcessingStatusDate>2017-12-20</ProcessingStatusDate>
        <EnteredBy>kuhlmanna</EnteredBy>
        
       </ProcessingStatus><ProcessingStatus>
        <ProcessingStatusValue>Copyright Permissions Received</ProcessingStatusValue>
        <ProcessingStatusDate>2017-12-20</ProcessingStatusDate>
        <EnteredBy>kuhlmanna</EnteredBy>
        
       </ProcessingStatus><ProcessingStatus>
        <ProcessingStatusValue>Processing Complete</ProcessingStatusValue>
        <ProcessingStatusDate>2017-12-11</ProcessingStatusDate>
        <EnteredBy>saucedol</EnteredBy>
        
       </ProcessingStatus><ProcessingStatus>
        <ProcessingStatusValue>Translation pending</ProcessingStatusValue>
        <ProcessingStatusDate>2017-11-30</ProcessingStatusDate>
        <EnteredBy>lansberryic</EnteredBy>
        <Comment>Translation of Caption and Content. Descrp. Pending QC</Comment>
       </ProcessingStatus><ProcessingStatus>
        <ProcessingStatusValue>Copyright Permissions Pending</ProcessingStatusValue>
        <ProcessingStatusDate>2017-11-29</ProcessingStatusDate>
        <EnteredBy>kuhlmanna</EnteredBy>
        
       </ProcessingStatus>
  <ProcessingStatus>
   <ProcessingStatusValue>HP illustration approved</ProcessingStatusValue>
   <ProcessingStatusDate>2017-11-29</ProcessingStatusDate>
   <EnteredBy>kuhlmanna</EnteredBy>
   <Comment>Image approved by Pediatric Treatment Editorial Board</Comment>
  </ProcessingStatus>
 </ProcessingStatuses>
<RelatedDocuments>
         <SupplementaryInfoLink cdr:ref="CDR0000791692">Baselga_ChVascularTumors_CopyrightPermissions_2017-12-20</SupplementaryInfoLink>
       </RelatedDocuments></Media>
